Specialized Health Services Stocks on Investors' Radar -- DaVita, Acadia Healthcare, HealthSouth, and MEDNAX

Wednesday, May 3, 2017 General News
Email Print This Page Comment bookmark
Font : A-A+

NEW YORK, May 3, 2017 /PRNewswire/ --

On Tuesday, benchmark US indices were in bullish colors as the NASDAQ Composite

closed the trading session up 0.06%; the Dow Jones Industrial Average edged 0.17% higher; and the S&P 500 was up 0.12%. US markets made broad based gains with five out of nine sectors finishing the day in green. Pre-market today, Stock-Callers.com
reviews these four Specialized Health Services stocks: DaVita Inc. (NYSE: DVA), Acadia Healthcare Company Inc. (NASDAQ: ACHC), HealthSouth Corporation (NYSE: HLS), and MEDNAX Inc. (NYSE: MD). Learn more about these stocks by accessing their free research reports at:

http://stock-callers.com/registration

DaVita  

On Tuesday, shares in Denver, Colorado headquartered DaVita Inc. recorded a trading volume of 1.95 million shares, which was above their three months average volume of 1.14 million shares. The stock ended the day 1.46% higher at $70.09. Shares of the Company, which provides kidney dialysis services for patients suffering from chronic kidney failure or end stage renal disease, are trading at a PE ratio of 16.35. DaVita's stock has advanced 3.12% in the last one month and 9.95% in the previous three months. The Company's shares are trading above its 50-day and 200-day moving averages by 2.83% and 6.21%, respectively. Furthermore, DaVita's shares have a Relative Strength Index (RSI) of 63.68. Free research report on DVA is available at:

http://stock-callers.com/registration/?symbol=DVA

Acadia Healthcare  

Franklin, Tennessee headquartered Acadia Healthcare Co. Inc.'s stock finished Tuesday's session 3.30% higher at $45.39 with a total volume of 1.77 million shares traded. Over the last one month and the previous three months, Acadia Healthcare's shares have gained 4.11% and 18.30%, respectively. The Company's shares are trading above its 50-day and 200-day moving averages by 5.33% and 4.69%, respectively. Shares of Acadia Healthcare, which develops and operates inpatient psychiatric facilities, residential treatment centers, group homes, substance abuse facilities, and outpatient behavioral healthcare facilities to serve the behavioral health and recovery needs of communities in the US, the UK, and Puerto Rico, are trading at a PE ratio of 308.78. The stock has an RSI of 61.95.

On April 05th, 2017, research firm Deutsche Bank initiated a 'Buy' rating on the Company's stock, with a target price of $53 per share. The complimentary research report on ACHC can be downloaded at:

http://stock-callers.com/registration/?symbol=ACHC

HealthSouth  

Birmingham, Alabama headquartered HealthSouth Corp.'s stock advanced 1.06%, to close the day at $47.80. The stock recorded a trading volume of 1.49 million shares, which was above its three months average volume of 788,580 shares. HealthSouth's shares have gained 11.66% in the last one month, 23.83% in the previous three months, and 17.28% in the past one year. The Company's shares are trading 12.06% and 16.96% above its 50-day and 200-day moving averages, respectively. Shares of the Company, which provides facility-based and home-based post-acute healthcare services in the US, are trading at a PE ratio of 18.84. Additionally, the stock has an RSI of 80.60. Visit us today and access our complete research report on HLS at:

http://stock-callers.com/registration/?symbol=HLS

MEDNAX  

On Tuesday, shares in Sunrise, Florida headquartered MEDNAX Inc. ended the session 1.13% higher at $60.81 with a total volume of 1.20 million shares traded. Shares of the Company, which together with its subsidiaries, provides neonatal, anesthesia, maternal-fetal, and other pediatric subspecialties physician services in the US and Puerto Rico, are trading at a PE ratio of 17.41. The stock is trading 10.76% below its 50-day moving average and 9.33% below its 200-day moving average. Moreover, the Company's shares have an RSI of 24.12. Get free access to your research report on MD at:

http://stock-callers.com/registration/?symbol=MD

--

Stock Callers: 

Stock Callers (SC) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. SC has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below. 

SC has not been compensated; directly or indirectly; for producing or publishing this document. 

PRESS RELEASE PROCEDURES:

The non-sponsored content contained herein has been prepared by a writer (the "Author") and is fact checked and reviewed by a third party research service company (the "Reviewer") represented by a credentialed financial analyst [for further information on analyst credentials, please email [email protected]. Rohit Tuli, a CFA® charterholder (the "Sponsor"), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by SC. SC is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.  

NO WARRANTY 

SC, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. SC, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, SC, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice. 

NOT AN OFFERING 

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither SC nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit

http://stock-callers.com/legal-disclaimer/

CONTACT For any questions, inquiries, or comments reach out to us directly. If you're a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at: Email: [email protected] Phone number:  +44-330-808-3765 Office Address: Clyde Offices, Second Floor, 48 West George Street, Glasgow, U.K. -G2 1BP

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE Chelmsford Park SA



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store